Stargardt Disease 1
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease (NCT05244304) | Belite Bio, Inc | 2022-03-28 |
| Structural and Functional Characterization of Rare Ocular Diseases (NCT05258032) | Barcelona Macula Foundation | 2021-11-24 |
| Study of STG-001 in Subjects With Stargardt Disease (NCT04489511) | Stargazer Pharmaceuticals, Inc. | 2020-10-01 |
| Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease (NCT03297515) | Ophthalmos Research and Education Institute | 2019-05-15 |
| Stem Cells Therapy in Degenerative Diseases of the Retina (NCT03772938) | Pomeranian Medical University Szczecin | 2018-12-13 |
| Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision (NCT04281732) | Queen's University, Belfast | 2018-10-01 |
Track Stargardt Disease 1 automatically
Every clearance here is in the API, with alerts when new ones post.